Etanercept (TNF receptor fusion protein, enbrel®) is effective and well tolerated in active refractory Crohn's disease: Results of a single center pilot trial

✍ Scribed by D'Haens, Geert; Swijsen, Caroline; Noman, Maja; Lemmens, Liesbeth; Geboes, Karel; Rutgeerts, Paul

• Book ID: 123600100
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 180 KB
• Volume: 118
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(00)84762-9